Asian biopharmaceutical firms, key source of R&D pipeline

Published: 2008-04-18 06:56:00

Updated: 2008-04-18 06:56:00

Asian biopharmaceutical firms will become key players in the global bioindustry arena as they have well trained researchers with their governments' full support in finance, according to LG Life Sciences President Kim In-chul, who took part in BioMedical Asia 2008, taking place 14 - 17 April 2008 ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK